KR920002594A - 5-이소티아졸아민 유도체 - Google Patents

5-이소티아졸아민 유도체 Download PDF

Info

Publication number
KR920002594A
KR920002594A KR1019910011155A KR910011155A KR920002594A KR 920002594 A KR920002594 A KR 920002594A KR 1019910011155 A KR1019910011155 A KR 1019910011155A KR 910011155 A KR910011155 A KR 910011155A KR 920002594 A KR920002594 A KR 920002594A
Authority
KR
South Korea
Prior art keywords
isothiazolamine
derivative
pharmaceutically acceptable
general formula
protecting group
Prior art date
Application number
KR1019910011155A
Other languages
English (en)
Inventor
데 보 에르 티이스
Original Assignee
에프.지.엠.헤르 만스·에이.지.제이.베르 메렌
악조 엔. 브이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프.지.엠.헤르 만스·에이.지.제이.베르 메렌, 악조 엔. 브이 filed Critical 에프.지.엠.헤르 만스·에이.지.제이.베르 메렌
Publication of KR920002594A publication Critical patent/KR920002594A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

5-이소티아졸아민 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 하기 일반식(Ⅰ)의 5-이소티아졸아민 유도체 또는 이들의 약학적 허용 산부가염
    상기식에서 R1은 수소, 메틸 또는 에틸이고, R2와 R3는 수소 및 알킬에서 각각 선택되고, 점선은 임의의 결합을 나타냄.
  2. 제1항에 있어서, 하기 구조식을 가지는 것인 5-이소티아졸아민 유도체 또는 이의 약학적 허용 산부 감염,
  3. 하기 일반식(Ⅱ)의 피리디늄 유도체(R1은 메틸, 에틸 또는 보호기이고, R2와 R3는 제1항에서 정의한 바와 같거나 보호기를 나타내고, X-는 음이온임)를 환원시켜 보호기가 있다면 이를 제거한 후, 획득한 화합물을 일반식(Ⅰ)의 다른 화합물로 전화 및/또는 약학적 허용 산부가염으로 임의로 전환시키는 것을 특징으로 하는 제1항의 5-이소타아졸아민 유도체를 제조하는 방법.
  4. 약학적 허용 보조제와 함께 1항의 5-이소티아졸아민 유도체를 포함하는 약학적 조성물.
  5. α2-아드레날린성 효능작용을 하는 약물을 제조하는데 제1항의 5-이소티아졸아민 유도체를 사용하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910011155A 1990-07-03 1991-07-02 5-이소티아졸아민 유도체 KR920002594A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90307246 1990-07-03
EP90307246.0 1990-07-03

Publications (1)

Publication Number Publication Date
KR920002594A true KR920002594A (ko) 1992-02-28

Family

ID=8205476

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910011155A KR920002594A (ko) 1990-07-03 1991-07-02 5-이소티아졸아민 유도체

Country Status (11)

Country Link
US (1) US5179110A (ko)
EP (1) EP0464946A1 (ko)
JP (1) JPH04230379A (ko)
KR (1) KR920002594A (ko)
AU (1) AU641513B2 (ko)
CA (1) CA2045003A1 (ko)
FI (1) FI913173A (ko)
IE (1) IE911994A1 (ko)
NZ (1) NZ238796A (ko)
PT (1) PT98184A (ko)
ZA (1) ZA914675B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101209343B1 (ko) * 2005-10-07 2012-12-06 엘지전자 주식회사 샘플링속도조절기능의 터치패널장치 및 그 제어방법

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565475A (en) * 1994-11-08 1996-10-15 Muhlhauser; Mark A. Method of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivatives
DE19514579A1 (de) 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
US5668148A (en) * 1995-04-20 1997-09-16 Merck & Co., Inc. Alpha1a adrenergic receptor antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650805A (en) * 1985-12-02 1987-03-17 Warner-Lambert Company 4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines and 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamines having anti-psychotic activity
GB8610432D0 (en) * 1986-04-29 1986-06-04 Akzo Nv Amino-thiazole & oxazole derivatives
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
DK162892C (da) * 1988-07-04 1992-05-11 Novo Nordisk As 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
IT1229491B (it) * 1988-12-28 1991-09-03 Roussel Maestretti S P A Ora R Derivati della 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro impiego come sostanze medicinali

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101209343B1 (ko) * 2005-10-07 2012-12-06 엘지전자 주식회사 샘플링속도조절기능의 터치패널장치 및 그 제어방법

Also Published As

Publication number Publication date
FI913173A0 (fi) 1991-06-28
US5179110A (en) 1993-01-12
FI913173A (fi) 1992-01-04
IE911994A1 (en) 1992-01-15
ZA914675B (en) 1992-04-29
EP0464946A1 (en) 1992-01-08
PT98184A (pt) 1992-05-29
JPH04230379A (ja) 1992-08-19
AU641513B2 (en) 1993-09-23
NZ238796A (en) 1992-12-23
AU7949691A (en) 1992-02-27
CA2045003A1 (en) 1992-01-04

Similar Documents

Publication Publication Date Title
KR940007022A (ko) 피패리딘 유도체, 이것의 제법 및 치료에 있어서 이것의 이용
KR850002472A (ko) 5-피리딜-1,3-티아졸 유도체의 제조방법
KR950017957A (ko) 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체
KR880012526A (ko) l-페닐-3-나프탈레닐옥시프로판아민
KR950014073A (ko) 이소퀴놀린
KR900016220A (ko) 매크로리드 조성물
KR850003402A (ko) 2-아미노-5-하이드록시-4-메틸 피리미딘 유도체의 제조방법
KR930016436A (ko) 4, 13-디옥사바이사이클로[8.2.1]트리데세논유도체와 그의 제조방법, 그의 제조를 위한 중간체 및 이화합물이 함유된 약학조성물
KR850006187A (ko) 신규 히달토인(Hydantoin) 유도체의 제조방법
KR910009672A (ko) 피리다진 유도체, 이의 제조방법 및 이것을 함유하는 약학 조성물
KR900018048A (ko) 환 치환된 2-아미노-1,2,3,4-테트라하이드로나프탈렌
KR900001715A (ko) Bu-3608 유도체
KR920002517A (ko) 칼모둘린 억제 특성을 갖는 벤즈히드릴 유도체 및 그의 제조방법
KR920002594A (ko) 5-이소티아졸아민 유도체
KR920007995A (ko) 벤즈아미드 유도체
KR850001903A (ko) 2,6-이중치환-1,4-디하이드로피리딘 유도체의 제조방법과 이것을 포함하는 약학적 조성물
KR850008491A (ko) 신규 세팔로스포린의 제조방법
KR900701763A (ko) 1-아미노-5-할로게노우라실, 그의 제조방법 및 이 화합물을 유효성분으로 함유하는 중추신경억제제
KR850005228A (ko) 살균제인 아미노알칸포스폰산 및 그 유도체
KR840001160A (ko) 벤조디옥산-이미다졸린 유도체의 제조방법
KR920005720A (ko) 피리딘 유도체 그 제조방법 및 그 약학적 조성물
KR850000415A (ko) 퀴나졸리논 유도체의 제조방법
KR850001188A (ko) 벤조푸란 유도체의 제조방법 및 조성물
KR860001815A (ko) 옥타하이드로-옥사졸로[4,5-g]퀴놀린의 제조방법
KR930000504A (ko) 2-피페리디닐 피리미딘-4-카르복시아미드 유도체의 제법 및 치료에의 이용

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid